You are here

Article info

Article menu
Download PDFPDF
Editorial
COVID-19: another reason for anticoagulation in patients with atrial fibrillation

Authors

  • Pekka Raatikainen Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Riitta Lassila Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Center, Helsinki University Hospital, and Reserach Program Unit of Systems Oncology, University of Helsinki, Helsinki, Finland, Helsinki, Finland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Pekka Raatikainen, Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki 00029, Finland; pekka.raatikainen{at}hus.fi
View Full Text

Citation

Raatikainen P, Lassila R
COVID-19: another reason for anticoagulation in patients with atrial fibrillation
Heart 2022;108:902-904.

Publication history

  • First published March 21, 2022.
Online issue publication 
November 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage